2018
DOI: 10.1097/rlu.0000000000002098
|View full text |Cite
|
Sign up to set email alerts
|

18F-FDG PET/CT in Anti-NMDA Receptor Encephalitis

Abstract: We report the case of a 28-year-old woman presenting behavior disorders of subacute onset. She was referred in our institution for a suspicion of limbic encephalitis. F-FDG PET/CT did not show any mesiotemporal abnormality but depicted a decreased uptake of bilateral parietal and occipital lobes. This atypical pattern was compatible with an anti-N-methyl-D-aspartate receptor encephalitis that was later confirmed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0
2

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(11 citation statements)
references
References 7 publications
0
9
0
2
Order By: Relevance
“…The results of PET analysis between patients with scans < 12 weeks from symptom onset and those ≥ 12 weeks from symptom onset showed no significant difference in the present study. Although some cases have reported that the duration of symptom onset is related to the metabolic pattern of autoimmune encephalitis ( 11 , 24 , 38 , 39 ), whether and how the duration of symptom onset influences the metabolic pattern has not been concluded in a large sample prospective study. Compared with the duration of symptom onset, daily activities score of patients can reflect objectively the stage of autoimmune encephalitis.…”
Section: Discussionmentioning
confidence: 99%
“…The results of PET analysis between patients with scans < 12 weeks from symptom onset and those ≥ 12 weeks from symptom onset showed no significant difference in the present study. Although some cases have reported that the duration of symptom onset is related to the metabolic pattern of autoimmune encephalitis ( 11 , 24 , 38 , 39 ), whether and how the duration of symptom onset influences the metabolic pattern has not been concluded in a large sample prospective study. Compared with the duration of symptom onset, daily activities score of patients can reflect objectively the stage of autoimmune encephalitis.…”
Section: Discussionmentioning
confidence: 99%
“…Literature Review on 18 F-FDG-PET Findings in Subtypes of AE A total of 124 subjects with AE and PET scans were reviewed as shown in Table 4. For anti-NMDAR encephalitis, 18 F-FDG-PET mainly presented with hypometabolism in the occipital (63%) and parietal (42%) areas, in the BG (33%) and the temporal lobe (29%) (14,(19)(20)(21)(22)(23)(24)(25)(26)(27). Patients with CASPR2 and GABAB showed no specific metabolic pattern due to the limitations regarding the number of cases (19,(30)(31)(32).…”
Section: F-fdg-pet Pattern Among Subtypes Of Lgi1 Ae Patientsmentioning
confidence: 99%
“… 16 , 21 In addition, patients with anti‐NMDAR encephalitis usually show a relative hypermetabolism in the frontal, temporal lobe and basal ganglia, hypometabolism in the parietal and occipital lobe. 22 , 23 , 24 , 25 Hence, compared with anti‐LGI1 and anti‐NMDAR encephalitis, patients with anti‐GABAB receptor encephalitis usually have limited involvement of the basal ganglia, which suggests that, in addition to whole‐body tumor screening, 18 F‐FDG‐PET may also be helpful in differentiating antibodies subtypes of AE. However, the sample size is relatively small and the pathophysiological mechanism of this metabolic signature, which might be related to the distribution of GABAB or other receptors in the brain, is still unclear.…”
Section: Discussionmentioning
confidence: 99%
“…In encephalitis associated with LGI1 antibody, MTL and basal ganglia hypermetabolism have been systematically described 16,21 . In addition, patients with anti‐NMDAR encephalitis usually show a relative hypermetabolism in the frontal, temporal lobe and basal ganglia, hypometabolism in the parietal and occipital lobe 22–25 . Hence, compared with anti‐LGI1 and anti‐NMDAR encephalitis, patients with anti‐GABAB receptor encephalitis usually have limited involvement of the basal ganglia, which suggests that, in addition to whole‐body tumor screening, 18 F‐FDG‐PET may also be helpful in differentiating antibodies subtypes of AE.…”
Section: Discussionmentioning
confidence: 99%